000 | 01973 a2200493 4500 | ||
---|---|---|---|
005 | 20250515160055.0 | ||
264 | 0 | _c20090610 | |
008 | 200906s 0 0 eng d | ||
022 | _a0363-6135 | ||
024 | 7 |
_a10.1152/ajpheart.00436.2008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaotome, Masao | |
245 | 0 | 0 |
_aTransient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Heart and circulatory physiology _cApr 2009 |
||
300 |
_aH1125-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCyclosporine _xpharmacology |
650 | 0 | 4 |
_aFluoresceins _xmetabolism |
650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Potential, Mitochondrial _xdrug effects |
650 | 0 | 4 |
_aMitochondria, Heart _xdrug effects |
650 | 0 | 4 |
_aMitochondrial Membrane Transport Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aMitochondrial Permeability Transition Pore |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aMyocardium _xcytology |
650 | 0 | 4 |
_aMyocytes, Cardiac _xcytology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReactive Oxygen Species _xpharmacology |
650 | 0 | 4 |
_aReperfusion Injury _xmetabolism |
650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
700 | 1 | _aKatoh, Hideki | |
700 | 1 | _aYaguchi, Yasuhiro | |
700 | 1 | _aTanaka, Takamitsu | |
700 | 1 | _aUrushida, Tsuyoshi | |
700 | 1 | _aSatoh, Hiroshi | |
700 | 1 | _aHayashi, Hideharu | |
773 | 0 |
_tAmerican journal of physiology. Heart and circulatory physiology _gvol. 296 _gno. 4 _gp. H1125-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpheart.00436.2008 _zAvailable from publisher's website |
999 |
_c18646175 _d18646175 |